Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors
  2. Bahta, M.; Liu, F.; Kim, S. E.; Stephen, A. G.; Fisher, R. J.; Burke, T. R.
  3. Nature Protocols. 2012, Apr; 7(4): 686-702.
  1. 2.   Elucidation of New Binding Interactions with the Human Tsg101 Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands
  2. Kim, S. E.; Liu, F.; Im, Y. J.; Stephen, A. G.; Fivash, M. J.; Waheed, A. A.; Freed, E. O.; Fisher, R. J.; Hurley, J. H.; Burke, T. R.
  3. Acs Medicinal Chemistry Letters. 2011, May; 2(5): 337-341.
  1. 3.   Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly
  2. Votteler, J.; Neumann, L.; Hahn, S.; Hahn, F.; Rauch, P.; Schmidt, K.; Studtrucker, N.; Solbak, S. M. O.; Fossen, T.; Henklein, P.; Ott, D. E.; Holl, G.; Bannert, N.; Schubert, U.
  3. Retrovirology. 2011, Feb; 8: 16.
  1. 4.   Crystallographic and Functional Analysis of the ESCRT-I/HIV-1 Gag PTAP Interaction
  2. Im, Y. J.; Kuo, L.; Ren, X. F.; Burgos, P. V.; Zhao, X. Z.; Liu, F.; Burke, T. R.; Bonifacino, J. S.; Freed, E. O.; Hurley, J. H.
  3. Structure. 2010, Nov; 18(11): 1536-1547.
  1. 5.   Functional role of Alix in HIV-1 replication
  2. Fujii, K.; Munshi, U. M.; Ablan, S. D.; Demirov, D. G.; Soheilian, F.; Nagashima, K.; Stephen, A. G.; Fisher, R. J.; Freed, E. O.
  3. Virology. 2009 391(2): 284-292.
  1. 6.   Protected aminooxyprolines for expedited library synthesis: Application to Tsg101-directed proline-oxime containing peptides
  2. Liu, F.; Stephen, A. G.; Fisher, R. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2008 18(3): 1096-1101.
  1. 7.   SAR by oxime-containing peptide libraries: Application to Tsg101 ligand optimization
  2. Liu, F.; Stephen, A. G.; Waheed, A. A.; Aman, M. J.; Freed, E. O.; Fisher, R. J.; Burke, T. R.
  3. Chembiochem. 2008 9(12): 2000-2004.
  1. 8.   3 molecular characterization of feline immunodeficiency virus budding
  2. Luttge, B. G.; Shehu-Xhilaga, M.; Demirov, D. G.; Adamson, C. S.; Soheilian, F.; Nagashima, K.; Stephen, A. G.; Fisher, R. J.; Freed, E. O.
  3. Journal of Virology. 2008 82(5): 2106-2119.
  1. 9.   Peptide Inhibitors of HIV-1 Egress
  2. Waheed, A. A.; Freed, E. O.
  3. Acs Chemical Biology. 2008 3(12): 745-747.
  1. 10.   The role of WWP1-Gag interaction and gag ubiquitination in assembly and release of human T-Cell leukemia virus type 1
  2. Heidecker, G.; Lloyd, P. A.; Soheilian, F.; Nagashima, K.; Derse, D.
  3. Journal of Virology. 2007, Sep; 81(18): 9769-9777.
  1. 11.   Structural basis for viral late-domain binding to Alix
  2. Lee, S.; Joshi, A.; Nagashima, K.; Freed, E. O.; Hurley, J. H.
  3. Nature Structural & Molecular Biology. 2007, Mar; 14(3): 194-199.
  1. 12.   Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release
  2. Heidecker, G.; Lloyd, P. A.; Fox, K.; Nagashima, K.; Derse, D.
  3. Journal of Virology. 2004 78(12): 6636-6648.
  1. 13.   PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 gag and mediates its functional interaction with cellular proteins nedd4 and Tsg101 (vol 77, pg 11882, 2003)
  2. Bouamr, F.; Melillo, J. A.; Wang, M. Q.; Nagashima, K.; Los Santos, M.; Rein, A.; Goff, S. P.
  3. Journal of Virology. 2004 78(8): 4383-4383.
  1. 14.   Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body
  2. Ono, A.; Freed, E. O.
  3. Journal of Virology. 2004 78(3): 1552-1563.
  1. 15.   Late domain-dependent inhibition of equine infectious anemia virus budding
  2. Miranda, S. X.; Ablan, S.; Demirov, D. G.; Chen, C. P.; Montelaro, R. C.; Freed, E. O.
  3. Journal of Virology. 2004 78(2): 724-732.
  1. 16.   Gene expression and viral prodution in latently infected, resting CD4(+) T cells in viremic versus aviremic HIV-infected individuals
  2. Chun, T. W.; Justement, J. S.; Lempicki, R. A.; Yang, J.; Dennis, G.; Hallahan, C. W.; Sanford, C.; Pandya, P.; Liu, S. Y.; McLaughlin, M.; Ehler, L. A.; Moir, S.; Fauci, A. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2003 100(4): 1908-1913.
  1. 17.   In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding
  2. Panchal, R. G.; Ruthel, G.; Kenny, T. A.; Kallstrom, G. H.; Lane, D.; Badie, S. S.; Li, L. M.; Bavari, S.; Aman, M. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2003 100(26): 15936-15941.
  1. 18.   Molecular mechanisms of filovirus cellular trafficking
  2. Aman, M. J.; Bosio, C. M.; Panchal, R. G.; Burnett, J. C.; Schmaljohn, A.; Bavari, S.
  3. Microbes and Infection. 2003 5(7): 639-649.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel